Brand name: Velabine TM
Active ingredients: vinorelbine
What it is used for
Non-small cell lung cancer: Velabine is indicated for the first line treatment of advanced non-small cell lung cancer, as a single agent or in combination. ,Breast cancer: Velabine is indicated for the treatment of advanced breast cancer after failure of standard therapy as a single agent or in combination.
How to take it
The way to take this medicine is: Oral. This medicine is taken by mouth.
- Store at 2 to 8 degrees Celsius
- Do not Freeze
- Shelf lifetime is 36 Months.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Visual appearance
oblong-shaped pink soft capsule
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Is this medicine subsidised?
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on April 1, 2024. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
Pregnant or planning a pregnancy?
For the active ingredient vinorelbine
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Download leaflet
For side effects, taking other medicines and more
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems